Repeated low-flow sevoflurane anesthesia: Effects on hepatic and renal function in beagles

Japanese Journal of Anesthesiology

Volumn 46, Issue 3, 1998, Pages 351-357

  Sun, Li ^a   Suzuki, Yasuyuki ^a   Takata, Masao ^a   Miyasaka, Katsuyuki ^a  

^a NATIONAL CHILDREN S HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORIDE; SEVOFLURANE;

ANIMAL EXPERIMENT; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; DOG; DOSE RESPONSE; INHALATION ANESTHESIA; KIDNEY FUNCTION; LIVER FUNCTION; MINIMUM LUNG ALVEOLUS CONCENTRATION; NONHUMAN;

ACETYLGLUCOSAMINIDASE; ANESTHESIA, INHALATION; ANESTHETICS, INHALATION; ANIMALS; ASPARTATE AMINOTRANSFERASES; CREATININE; DOGS; ETHERS; FLUORIDES; KIDNEY; KIDNEY FUNCTION TESTS; LIVER; LIVER FUNCTION TESTS; METHYL ETHERS;

EID: 8244247776     PISSN: 00214892     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Shiraishi Y, Ikeda K : Uptake and biotransformation of sevoflurane in humans : A comparative study of sevoflurane with halothane, enflurane, and isoflurane. J Clin Anesth 2: 381, 1990
2. Cook TL, Beppu WJ, Hitt BA, et al: Ranal effects and metabolism of sevoflurane in Fischer 344 rats : an in-vivo and in-vitro comparison with methoxyflurane. Anesthesiology 43: 70, 1975
3. Frink EJ Jr, Ghantous H, Malan TP, et al: Plasma inorganic fluoride with sevoflurane anesthesia : Correlation with indices of hepatic and renal function. Anesth Analg 74: 231, 1992
4. Malan TP, Kadota Y, Mata H, et al: Renal function after sevoflurane or enflurane anesthesia in the Fischer 344 rat. Anesth Analg 77: 817, 1993
5. Mazze RI: The safety of sevoflurane in humans. Anesthesiology 77: 1062, 1992
6. Morio M, Fujii K, Satoh N, et al: Reaction of sevoflurane and its degradation products with soda lime: Toxicity of the byproducts. Anesthesiology 77: 1155, 1992
7. Bito H, Ikeda K: Long-duration, low-flow sevoflurane anesthesia using two carbon dioxide absorbents: Quantification of degradation products in the circuit. Anesthesiology 81: 340, 1994
8. Hanaki C, Fujii K, Morio M, et al: Decomposition of sevoflurane by sodalime. Hiroshima J Med Sci 36: 61, 1987
9. Hubbard AK, Roth TP, Gandolfi AJ, et al: Halothane hepatitis patients generate an antibody response toward a covalently bound metabolite of halothane. Anesthesiology 68: 791, 1988
10. Motuz DJ, Watson WA, Barlow JC, et al: The increase in urinary alanine aminopeptidase excretion associated with enflurane anesthesia is increased further by aminoglycosides. Anesth Analg 67: 770, 1988
11. Beck PR, Chaudhuri AK: Effect of tobramycin on urinary γ-glutamyltransferase activity studies in a case of renal carcinoma. Clin Chem 22: 528, 1976
12. Cousins M, Mazze RI: Methoxyflurane nephrotoxicity: a study of dose-response in man. JAMA 225: 1611, 1973
13. Baden JM, Rice SA, Mazze RI: Deuterated methoxyflurane anesthesia and renal function in Fischer 344 rats. Anesthesiology 56: 203, 1982
14. Suzuki Y, Sun L, Takata M, et al: Effects of prolonged sevoflurane and isoflurane low-flow anesthesia: histopathological study after 48 hour anesthesia in beagles. Anesthesiology 83: A336, 1995